James A. Schoeneck

2014 - DepoMed

In 2014, James A. Schoeneck earned a total compensation of $4.1M as Former President and Chief Executive Officer at DepoMed, a 68% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$525,000
Option Awards$1,360,894
Salary$620,058
Stock Awards$1,548,180
Other$14,320
Total$4,068,452

Schoeneck received $1.5M in stock awards, accounting for 38% of the total pay in 2014.

Schoeneck also received $525K in non-equity incentive plan, $1.4M in option awards, $620.1K in salary and $14.3K in other compensation.

Rankings

In 2014, James A. Schoeneck's compensation ranked 2,081st out of 13,032 executives tracked by ExecPay. In other words, Schoeneck earned more than 84.0% of executives.

ClassificationRankingPercentile
All
2,081
out of 13,032
84th
Division
Manufacturing
734
out of 4,966
85th
Major group
Chemicals And Allied Products
230
out of 1,686
86th
Industry group
Drugs
177
out of 1,365
87th
Industry
Pharmaceutical Preparations
147
out of 1,043
86th
Source: SEC filing on July 14, 2017.

Schoeneck's colleagues

We found five more compensation records of executives who worked with James A. Schoeneck at DepoMed in 2014.

2014

Matthew Gosling

DepoMed

General Counsel

2014

Thadd Vargas

DepoMed

Senior Vice President, Business Development

2014

August Moretti

DepoMed

Chief Financial Officer

2014

R Shively

DepoMed

Former Senior Vice President and Chief Commercial Officer

2014

Srinivas Rao

DepoMed

Chief Medical Officer

News

You may also like